{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:24:13Z","timestamp":1790742253706,"version":"4.1.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s11940-011-0115-z","type":"journal-article","created":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T07:01:47Z","timestamp":1296457307000},"page":"160-179","source":"Crossref","is-referenced-by-count":40,"title":["Inherited Neuropathies"],"prefix":"10.1007","volume":"13","author":[{"given":"Angelo","family":"Schenone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Nobbio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Monti Bragadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ursino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Grandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,1]]},"reference":[{"issue":"2","key":"115_CR1","first-page":"93","volume":"7","author":"MM Reilly","year":"2007","unstructured":"Reilly MM. Sorting out the inherited neuropathies. Pract Neurol. 2007;7(2):93\u2013105.","journal-title":"Pract Neurol"},{"key":"115_CR2","first-page":"1094","volume-title":"Peripheral neuropathy","author":"PJ Dyck","year":"1993","unstructured":"Dyck PJ, Chance P, Lebo R, Carney AJ. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Grillin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd ed. Philadelphia: WB Saunders; 1993. p. 1094\u2013136.","edition":"3"},{"issue":"12","key":"115_CR3","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/jnnp.2008.158295","volume":"80","author":"MM Reilly","year":"2009","unstructured":"Reilly MM, Shy ME. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry. 2009;80(12):1304\u201314. This review focuses on the clinical management of hereditary neuropathies, particularly of the Charcot-Marie-Tooth type, and offers helpful, practical suggestions to clinicians.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"115_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/lv.2000.6145","volume":"6","author":"OB Suhr","year":"2000","unstructured":"Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transplant. 2000;6(3):263\u201376.","journal-title":"Liver Transplant"},{"issue":"3","key":"115_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10072-009-0211-y","volume":"31","author":"A Salviati","year":"2010","unstructured":"Salviati A, Burlina AP, Borsini W. Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy. Neurol Sci. 2010;31(3):299\u2013306.","journal-title":"Neurol Sci"},{"issue":"Suppl 2","key":"115_CR6","first-page":"S16","volume":"81","author":"AM Yeager","year":"2002","unstructured":"Yeager AM. Allogeneic hematopoietic cell transplantation for inborn metabolic diseases. Ann Hematol. 2002;81 Suppl 2:S16\u201319.","journal-title":"Ann Hematol"},{"issue":"5","key":"115_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00019052-199910000-00015","volume":"12","author":"A Schenone","year":"1999","unstructured":"Schenone A, Mancardi GL. Molecular basis of inherited neuropathies. Curr Opin Neurol. 1999;12(5):603\u201316.","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"115_CR8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/ana.410420607","volume":"42","author":"A Schenone","year":"1997","unstructured":"Schenone A, Nobbio L, Caponnetto C, Abbruzzese M, Mandich P, Bellone E, et al. Correlation between PMP-22 messenger RNA expression and phenotype in hereditary neuropathy with liability to pressure palsies. Ann Neurol. 1997;42(6):866\u201372.","journal-title":"Ann Neurol"},{"issue":"4","key":"115_CR9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nurt.2008.07.001","volume":"5","author":"DN Herrmann","year":"2008","unstructured":"Herrmann DN. Experimental therapeutics in hereditary neuropathies: the past, the present, and the future. Neurotherapeutics. 2008;5(4):507\u201315.","journal-title":"Neurotherapeutics"},{"issue":"10","key":"115_CR10","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/molehr\/4.10.978","volume":"4","author":"A Vos De","year":"1998","unstructured":"De Vos A, Sermon K, Van de Velde H, Joris H, Vandervorst M, Lissens W, et al. Pregnancy after preimplantation genetic diagnosis for Charcot-Marie-Tooth disease type 1A. Mol Hum Reprod. 1998;4(10):978\u201384.","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"115_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0492-29","volume":"1","author":"JR Lupski","year":"1992","unstructured":"Lupski JR, Wise CA, Kuwano A, Pentao L, Parke JT, Glaze DG, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992;1(1):29\u201333.","journal-title":"Nat Genet"},{"issue":"1","key":"115_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(93)90058-X","volume":"72","author":"PF Chance","year":"1993","unstructured":"Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993;72(1):143\u201351.","journal-title":"Cell"},{"issue":"5","key":"115_CR13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0896-6273(00)80128-2","volume":"16","author":"M Sereda","year":"1996","unstructured":"Sereda M, Griffiths I, P\u00fchlhofer A, Stewart H, Rossner MJ, Zimmerman F, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 1996;16(5):1049\u201360.","journal-title":"Neuron"},{"issue":"3","key":"115_CR14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ng1195-274","volume":"11","author":"K Adlkofer","year":"1995","unstructured":"Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet. 1995;11(3):274\u201380.","journal-title":"Nat Genet"},{"issue":"3","key":"115_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1193-269","volume":"5","author":"BB Roa","year":"1993","unstructured":"Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet. 1993;5(3):269\u201373.","journal-title":"Nat Genet"},{"issue":"2","key":"115_CR16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.brainresrev.2004.12.021","volume":"48","author":"RC Melcangi","year":"2005","unstructured":"Melcangi RC, Cavarretta IT, Ballabio M, Leonelli E, Schenone A, Azcoitia I, et al. Peripheral nerves: a target for the action of neuroactive steroids. Brain Res Brain Res Rev. 2005;48(2):328\u201338.","journal-title":"Brain Res Brain Res Rev"},{"issue":"12","key":"115_CR17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/nm957","volume":"9","author":"MW Sereda","year":"2003","unstructured":"Sereda MW. Meyer zu H\u00f6rste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med. 2003;9(12):1533\u20137.","journal-title":"Nat Med"},{"issue":"4","key":"115_CR18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nm1023","volume":"10","author":"E Passage","year":"2004","unstructured":"Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med. 2004;10(4):396\u2013401.","journal-title":"Nat Med"},{"key":"115_CR19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nmd.2006.12.008","volume":"17","author":"F Kaya","year":"2007","unstructured":"Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Font\u00e9s M. Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscul Disord. 2007;17:248\u201353.","journal-title":"Neuromuscul Disord"},{"key":"115_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1741-7015-7-70","volume":"7","author":"C Verhamme","year":"2009","unstructured":"Verhamme C, de Haan RJ, Vermeulen M, Baas F, de Visser M, van Schaik IN. Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial. BMC Med. 2009;7:70. This paper was the first to present data on the treatment with ascorbic acid of patients affected by CMT1A. Interestingly, although young patients have been included in the trial, the results are negative.","journal-title":"BMC Med"},{"key":"115_CR21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1474-4422(09)70108-5","volume":"8","author":"J Burns","year":"2009","unstructured":"Burns J, Ouvrier RA, Yiu EM, et al. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol. 2009;8:537\u201344. This paper basically replicated the negative results of reference [20], but in this case, children affected by CMT1A were treated with ascorbic acid.","journal-title":"Lancet Neurol"},{"key":"115_CR22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S1474-4422(09)70260-1","volume":"8","author":"J Micallef","year":"2009","unstructured":"Micallef J, Attarian S, Dubourg O, et al. A One-Year Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High Doses of Ascorbic Acid in Charcot-Marie-Tooth Disease Type 1A. Lancet Neurol. 2009;8:1103\u201310. This paper was the first to present data on the treatment of a large number of adult patients affected by CMT1A with two different dosages of ascorbic acid. Again, the overall results were negative.","journal-title":"Lancet Neurol"},{"key":"115_CR23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1212\/01.WNL.0000156517.00615.A3","volume":"64","author":"ME Shy","year":"2005","unstructured":"Shy ME, Blake J, Krajewski K, et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology. 2005;64:1209\u201314.","journal-title":"Neurology"},{"key":"115_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(09)70112-7","volume":"8","author":"M Shy","year":"2009","unstructured":"Shy M. Ascorbic acid for treatment of CMT1A: the jury is still out. Lancet Neurol. 2009;8:505\u20137.","journal-title":"Lancet Neurol"},{"key":"115_CR25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1474-4422(09)70270-4","volume":"8","author":"D Pareyson","year":"2009","unstructured":"Pareyson D, Solari A. Charcot-Marie-Tooth disease type 1A: is ascorbic acid effective? Lancet Neurol. 2009;8:1075\u20137.","journal-title":"Lancet Neurol"},{"issue":"1","key":"115_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nbd.2008.06.015","volume":"32","author":"S Rangaraju","year":"2008","unstructured":"Rangaraju S, Madorsky I, Pileggi JG, Kamal A, Notterpek L. Pharmacological induction of the heat shock response improves myelination in a neuropathic model. Neurobiol Dis. 2008;32(1):105\u201315. This paper underscores the role of stimulating the heat shock proteins (HSP) pathway to reduce negative effects of intracellular accumulation of mutated myelin proteins and promote myelination in experimental models of CMT. This view is particularly interesting, as mutations in the HSP may also cause HMN\/CMT2.","journal-title":"Neurobiol Dis"},{"issue":"Pt 7","key":"115_CR27","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/brain\/awp113","volume":"132","author":"I Katona","year":"2009","unstructured":"Katona I, Wu X, Feely SM, Sottile S, Siskind CE, Miller LJ, et al. PMP22 expression in dermal nerve myelin from patients with CMT1A. Brain. 2009;132(Pt 7):1734\u201340.","journal-title":"Brain"},{"issue":"2","key":"115_CR28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1523\/JNEUROSCI.18-02-00731.1998","volume":"18","author":"D D\u2019Urso","year":"1998","unstructured":"D\u2019Urso D, Prior R, Greiner-Petter R, Gabre\u00ebls-Festen AA, M\u00fcller HW. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci. 1998;18(2):731\u201340.","journal-title":"J Neurosci"},{"issue":"7","key":"115_CR29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnen\/62.7.751","volume":"62","author":"I Shames","year":"2003","unstructured":"Shames I, Fraser A, Colby J, Orfali W, Snipes GJ. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases. J Neuropathol Exp Neurol. 2003;62(7):751\u201364.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"115_CR30","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1523\/JNEUROSCI.3819-05.2006","volume":"26","author":"L Wrabetz","year":"2006","unstructured":"Wrabetz L, D\u2019Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, et al. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci. 2006;26(8):2358\u201368.","journal-title":"J Neurosci"},{"issue":"13","key":"115_CR31","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/hmg\/ddn083","volume":"17","author":"M Grandis","year":"2008","unstructured":"Grandis M, Vigo T, Passalacqua M, Jain M, Scazzola S, La Padula V, et al. Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations. Hum Mol Genet. 2008;17(13):1877\u201389.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"115_CR32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/hmg\/11.3.243","volume":"11","author":"P Dickinson","year":"2002","unstructured":"Dickinson P, Smith SN, Webb S, Kilanowski FM, Campbell IJ, Taylor MS, et al. The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics. Hum Mol Genet. 2002;11(3):243\u201351.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"115_CR33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMcibr041584","volume":"351","author":"P Zeitlin","year":"2004","unstructured":"Zeitlin P. Can curcumin cure cystic fibrosis? N Engl J Med. 2004;351(6):606\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"115_CR34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1086\/519926","volume":"81","author":"M Khajavi","year":"2007","unstructured":"Khajavi M, Shiga K, Wiszniewski W, He F, Shaw CA, Yan J, et al. Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet. 2007;81(3):438\u201353.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"115_CR35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/497541","volume":"77","author":"M Khajavi","year":"2005","unstructured":"Khajavi M, Inoue K, Wiszniewski W, Ohyama T, Snipes GJ, Lupski JR. Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. Am J Hum Genet. 2005;77(5):841\u201350.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"115_CR36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cell.2007.08.024","volume":"130","author":"S Singh","year":"2007","unstructured":"Singh S. From exotic spice to modern drug? Cell. 2007;130(5):765\u20138.","journal-title":"Cell"},{"issue":"1","key":"115_CR37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nbd.2009.01.002","volume":"34","author":"I Madorsky","year":"2009","unstructured":"Madorsky I, Opalach K, Waber A, Verrier JD, Solmo C, Foster T, et al. Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease. Neurobiol Dis. 2009;34(1):146\u201354. This paper is important because it introduces the concept of using a simple method of dietary restriction to treat an animal model of CMT.","journal-title":"Neurobiol Dis"},{"issue":"22","key":"115_CR38","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","volume":"21","author":"N Mizushima","year":"2007","unstructured":"Mizushima N. Autophagy: process and function. Genes Dev. 2007;21(22):2861\u201373.","journal-title":"Genes Dev"},{"issue":"5","key":"115_CR39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbabio.2009.02.021","volume":"1787","author":"F Celsi","year":"2009","unstructured":"Celsi F, Pizzo P, Brini M, Leo S, Fotino C, Pinton P, et al. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta. 2009;1787(5):335\u201344.","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 2","key":"115_CR40","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","volume":"20","author":"RH Swerdlow","year":"2010","unstructured":"Swerdlow RH, Burns JM, Khan SM. The Alzheimer\u2019s disease mitochondrial cascade hypothesis. J Alzheimers Dis. 2010;20 Suppl 2:S265\u201379.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"115_CR41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11910-009-0060-3","volume":"9","author":"KG Su","year":"2009","unstructured":"Su KG, Banker G, Bourdette D, Forte M. Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis. Curr Neurol Neurosci Rep. 2009;9(5):411\u201317.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"115_CR42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.21086","volume":"61","author":"D Loiseau","year":"2007","unstructured":"Loiseau D, Chevrollier A, Verny C, Guillet V, Gueguen N. Pou de Crescenzo MA, Ferr\u00e9 M, Malinge MC, Guichet A, Nicolas G, Amati-Bonneau P, Malthi\u00e8ry Y, Bonneau D, Reynier P. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann Neurol. 2007;61(4):315\u201323.","journal-title":"Ann Neurol"},{"issue":"6","key":"115_CR43","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/NEN.0b013e3181a5deeb","volume":"68","author":"ML Tradewell","year":"2009","unstructured":"Tradewell ML, Durham HD, Mushynski WE, Gentil BJ. Mitochondrial and axonal abnormalities precede disruption of the neurofilament network in a model of Charcot-Marie-Tooth disease type 2E and are prevented by heat shock proteins in a mutant-specific fashion. J Neuropathol Exp Neurol. 2009;68(6):642\u201352.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"19","key":"115_CR44","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1523\/JNEUROSCI.5265-09.2010","volume":"30","author":"S Kiryu-Seo","year":"2010","unstructured":"Kiryu-Seo S, Ohno N, Kidd GJ, Komuro H, Trapp BD. Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci. 2010;30(19):6658\u201366.","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"115_CR45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-4159.2009.05867.x","volume":"109","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Zheng L, Perry G, Smith MA, Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer\u2019s disease. J Neurochem. 2009;109 Suppl 1:153\u20139.","journal-title":"J Neurochem"},{"key":"115_CR46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"DT Chang","year":"2006","unstructured":"Chang DT, Rintoul GL, Pandipati S, Reynolds IJ. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis. 2006;22:388\u2013400.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"115_CR47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","volume":"36","author":"S Z\u00fcchner","year":"2004","unstructured":"Z\u00fcchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36(5):449\u201351.","journal-title":"Nat Genet"},{"issue":"Spec No. 2","key":"115_CR48","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1093\/hmg\/ddi270","volume":"14","author":"H Chen","year":"2005","unstructured":"Chen H, Chan DC. Emerging functions of mammalian mitochondrial fusion and fission. Hum Mol Genet. 2005;14(Spec No. 2):R283\u20139.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"115_CR49","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1523\/JNEUROSCI.6248-09.2010","volume":"30","author":"A Misko","year":"2010","unstructured":"Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro\/Milton complex. J Neurosci. 2010;30(12):4232\u201340.","journal-title":"J Neurosci"},{"issue":"4","key":"115_CR50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.21086","volume":"61","author":"D Loiseau","year":"2007","unstructured":"Loiseau D, Chevrollier A, Verny C, Guillet V, Gueguen N. Pou de Crescenzo MA, Ferr\u00e9 M, Malinge MC, Guichet A, Nicolas G, Amati-Bonneau P, Malthi\u00e8ry Y, Bonneau D, Reynier P. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann Neurol. 2007;61(4):315\u201323.","journal-title":"Ann Neurol"},{"issue":"3","key":"115_CR51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/hmg\/ddm314","volume":"17","author":"SA Detmer","year":"2008","unstructured":"Detmer SA. Vande Velde C, Cleveland DW, Chan DC. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A. Hum Mol Genet. 2008;17(3):367\u201375.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"115_CR52","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1083\/jcb.200507087","volume":"170","author":"A Niemann","year":"2005","unstructured":"Niemann A, Ruegg M, La Padula V, Schenone A, Suter U. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol. 2005;170(7):1067\u201378.","journal-title":"J Cell Biol"},{"issue":"3","key":"115_CR53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nbd.2009.09.011","volume":"36","author":"A Niemann","year":"2009","unstructured":"Niemann A, Wagner KM, Ruegg M, Suter U. GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance. Neurobiol Dis. 2009;36(3):509\u201320.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"115_CR54","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/NEN.0b013e3181a5deeb","volume":"68","author":"ML Tradewell","year":"2009","unstructured":"Tradewell ML, Durham HD, Mushynski WE, Gentil BJ. Mitochondrial and axonal abnormalities precede disruption of the neurofilament network in a model of Charcot-Marie-tooth disease type 2E and are prevented by heat shock proteins in a mutant-specific fashion. J Neuropathol Exp Neurol. 2009;68(6):642\u201352. This paper suggests, with convincing results, that HSP inducers have therapeutic potential for CMT2E and may be of help in planning future therapeutic strategies for axonal CMT.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"42","key":"115_CR55","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.1523\/JNEUROSCI.3649-04.2004","volume":"24","author":"G Corfas","year":"2004","unstructured":"Corfas G, Velardez MO, Ko CP, Ratner N, Peles E. Mechanisms and roles of axon-Schwann cell interactions. J Neurosci. 2004;24(42):9250\u201360.","journal-title":"J Neurosci"},{"issue":"5","key":"115_CR56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrneurol.2010.37","volume":"6","author":"C Taveggia","year":"2010","unstructured":"Taveggia C, Feltri ML, Wrabetz L. Signals to promote myelin formation and repair. Nat Rev Neurol. 2010;6(5):276\u201387. This is an exhaustive review of the mechanisms underlying the crosstalk between the Schwann cells and the axons and vice versa.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"115_CR57","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1523\/JNEUROSCI.10-06-01855.1990","volume":"10","author":"S Waegh De","year":"1990","unstructured":"De Waegh S, Brady ST. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci. 1990;10(6):1855\u201365.","journal-title":"J Neurosci"},{"issue":"Pt 7","key":"115_CR58","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/brain\/123.7.1516","volume":"123","author":"KM Krajewski","year":"2000","unstructured":"Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain. 2000;123(Pt 7):1516\u201327.","journal-title":"Brain"},{"issue":"5","key":"115_CR59","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/01.WNL.0000171978.70849.c5","volume":"65","author":"Z Sahenk","year":"2005","unstructured":"Sahenk Z, Nagaraja HN, McCracken BS, King WM, Freimer ML, Cedarbaum JM, et al. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology. 2005;65(5):681\u20139.","journal-title":"Neurology"},{"issue":"5","key":"115_CR60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/NEN.0b013e31819fa6ba","volume":"68","author":"L Nobbio","year":"2009","unstructured":"Nobbio L, Fiorese F, Vigo T, Cilli M, Gherardi G, Grandis M, et al. Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy. J Neuropathol Exp Neurol. 2009;68(5):441\u201355.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"115_CR61","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/13543784.15.8.897","volume":"15","author":"MC Mancini","year":"2006","unstructured":"Mancini MC, Halpern A. Investigational therapies in the treatment of obesity. Expert Opin Investig Drugs. 2006;15(8):897\u2013915.","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"115_CR62","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.20285","volume":"56","author":"SC Keswani","year":"2004","unstructured":"Keswani SC, Buldanlioglu U, Fischer A, Reed N, Polley M, Liang H, et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol. 2004;56(6):815\u201326.","journal-title":"Ann Neurol"},{"issue":"3","key":"115_CR63","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1073\/pnas.0307823100","volume":"101","author":"R Bianchi","year":"2004","unstructured":"Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, et al. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA. 2004;101(3):823\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"115_CR64","unstructured":"Wu Z, Mata M, Fink DJ. Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin. Mol Ther. 2010 Oct 5, (Epub ahead of print).This paper provides convincing proof-of-principle preclinical evidence for the development of regulatable vectors for clinical trials in peripheral neuropathies. In fact, it demonstrates that expression of EPO in DRG achieved from a regulatable vector efficiently protects against the progression of neuropathy in diabetic animals."},{"issue":"5681","key":"115_CR65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","volume":"305","author":"M Leist","year":"2004","unstructured":"Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004;305(5681):239\u201342.","journal-title":"Science"},{"issue":"34","key":"115_CR66","doi-asserted-by":"crossref","first-page":"23146","DOI":"10.1074\/jbc.M109.027128","volume":"284","author":"L Nobbio","year":"2009","unstructured":"Nobbio L, Sturla L, Fiorese F, Usai C, Basile G, Moreschi I, et al. P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy. J Biol Chem. 2009;284(34):23146\u201358. This paper identifies a possible new mechanism of Schwann cell damage in CMT1A neuropathy, mediated by an excessive influx of calcium in the cells due to opening of the P2X7 receptor. This is a putative target for pharmacologic therapy in CMT1A.","journal-title":"J Biol Chem"},{"issue":"5","key":"115_CR67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11910-009-0060-3","volume":"9","author":"KG Su","year":"2009","unstructured":"Su KG, Banker G, Bourdette D, Forte M. Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis. Curr Neurol Neurosci Rep. 2009;9(5):411\u201317.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"115_CR68","doi-asserted-by":"crossref","unstructured":"Ravera S, Panfoli I, Aluigi MG, Calzia D, Morelli A. Characterization of myelin sheath FoF1-ATP synthase and its regulation by IF1. Cell Biochem Biophys. 2010 Aug 31 (Epub ahead of print).","DOI":"10.1007\/s12013-010-9112-1"},{"issue":"7","key":"115_CR69","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.biocel.2009.01.009","volume":"41","author":"S Ravera","year":"2009","unstructured":"Ravera S, Panfoli I, Calzia D, Aluigi MG, Bianchini P, Diaspro A, et al. Evidence for aerobic ATP synthesis in isolated myelin vesicles. Int J Biochem Cell Biol. 2009;41(7):1581\u201391. This paper provides preliminary data suggesting an energetic role of the myelin sheath and may shed light on the relationship between demyelination and axonal degeneration. The authors found that isolated myelin vesicles (IMV) are able to consume O 2 and produce ATP and, by immunocytochemistry at the confocal microscope, that ATP synthase and myelin basic protein colocalize on both IMV and optic nerves.","journal-title":"Int J Biochem Cell Biol"},{"issue":"29","key":"115_CR70","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1523\/JNEUROSCI.1254-07.2007","volume":"27","author":"HB Werner","year":"2007","unstructured":"Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, et al. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci. 2007;27(29):7717\u201330.","journal-title":"J Neurosci"},{"issue":"34","key":"115_CR71","doi-asserted-by":"crossref","first-page":"14605","DOI":"10.1073\/pnas.0905936106","volume":"106","author":"A Ishii","year":"2009","unstructured":"Ishii A, Dutta R, Wark GM, Hwang SI, Han DK, Trapp BD, et al. Human myelin proteome and comparative analysis with mouse myelin. Proc Natl Acad Sci USA. 2009;106(34):14605\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"115_CR72","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF01175570","volume":"5","author":"AJ Aguayo","year":"1976","unstructured":"Aguayo AJ, Charron L, Bray GM. Potential of Schwann cells from unmyelinated nerves to produce myelin: a quantitative ultrastructural and radiographic study. J Neurocytol. 1976;5(8):565\u201373.","journal-title":"J Neurocytol"},{"issue":"3","key":"115_CR73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cne.901300304","volume":"130","author":"RL Friede","year":"1967","unstructured":"Friede RL, Samorajski T. Relation between the number of myelin lamellae and axon circumference in fibers of vagus and sciatic nerves of mice. J Comp Neurol. 1967;130(3):223\u201331.","journal-title":"J Comp Neurol"},{"issue":"18","key":"115_CR74","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1073\/pnas.93.18.9887","volume":"93","author":"C Demerens","year":"1996","unstructured":"Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, et al. Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci USA. 1996;93(18):9887\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5671","key":"115_CR75","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.1095862","volume":"304","author":"GV Michailov","year":"2004","unstructured":"Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science. 2004;304(5671):700\u20133.","journal-title":"Science"},{"issue":"5","key":"115_CR76","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2005.08.017","volume":"47","author":"C Taveggia","year":"2005","unstructured":"Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, et al. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron. 2005;47(5):681\u201394.","journal-title":"Neuron"},{"issue":"12","key":"115_CR77","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/nn1797","volume":"9","author":"X Hu","year":"2006","unstructured":"Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci. 2006;9(12):1520\u20135.","journal-title":"Nat Neurosci"},{"issue":"14","key":"115_CR78","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/glia.20750","volume":"56","author":"JL Salzer","year":"2008","unstructured":"Salzer JL, Brophy PJ, Peles E. Molecular domains of myelinated axons in the peripheral nervous system. Glia. 2008;56(14):1532\u201340.","journal-title":"Glia"},{"issue":"1-2","key":"115_CR79","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1385\/NMM:8:1:175","volume":"8","author":"IpC Wang","year":"2006","unstructured":"Wang IpC, Kroner A, Fischer S, Berghoff M, Kobsar I, M\u00e4urer M, et al. Role of immune cells in animal models for inherited peripheral neuropathies. Neuromolecular Med. 2006;8(1-2):175\u201390.","journal-title":"Neuromolecular Med"},{"issue":"2","key":"115_CR80","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1523\/JNEUROSCI.20-02-00729.2000","volume":"20","author":"CD Schmid","year":"2000","unstructured":"Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, et al. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci. 2000;20(2):729\u201335.","journal-title":"J Neurosci"},{"issue":"1","key":"115_CR81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2010.01.001","volume":"38","author":"B Kohl","year":"2010","unstructured":"Kohl B, Groh J, Wessig C, Wiendl H, Kroner A, Martini R. Lack of evidence for a pathogenic role of T-lymphocytes in an animal model for Charcot-Marie-Tooth disease 1A. Neurobiol Dis. 2010;38(1):78\u201384.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"115_CR82","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00227671","volume":"84","author":"A Vital","year":"1992","unstructured":"Vital A, Vital C, Julien J, Fontan D. Occurrence of active demyelinating lesions in children with hereditary motor and sensory neuropathy (HMSN) type I. Acta Neuropathol. 1992;84(4):433\u20136.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"115_CR83","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/WNL.38.6.848","volume":"38","author":"GL Mancardi","year":"1988","unstructured":"Mancardi GL, Cadoni A, Zicca A, Schenone A, Tabaton M, De Martini I, et al. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology. 1988;38(6):848\u201351.","journal-title":"Neurology"},{"key":"115_CR84","doi-asserted-by":"crossref","unstructured":"White CM, Pritchard J, Turner-Stokes L. Exercise for people with peripheral neuropathy. Cochrane Database Syst Rev. 2004;(4):CD003904.","DOI":"10.1002\/14651858.CD003904.pub2"},{"key":"115_CR85","doi-asserted-by":"crossref","unstructured":"Young P, De Conghe P, Stagbauer F, Butterfass-Bahloul T. Treatment for Charcot Marie Tooth disease. Cochrane Database Syst Rev. 2008 (1):CD006052","DOI":"10.1002\/14651858.CD006052.pub2"},{"issue":"7","key":"115_CR86","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0003-9993(95)80629-6","volume":"76","author":"E Lindeman","year":"1995","unstructured":"Lindeman E, Leffers P, Spaans F, Drukker J, Reulen J, Kerckhoffs M, et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil. 1995;76(7):612\u201320.","journal-title":"Arch Phys Med Rehabil"},{"issue":"7","key":"115_CR87","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0003-9993(93)90031-5","volume":"74","author":"SG Aitkens","year":"1993","unstructured":"Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1993;74(7):711\u201315.","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"115_CR88","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0003-9993(21)01620-8","volume":"75","author":"DD Kilmer","year":"1994","unstructured":"Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1994;75(5):560\u20133.","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"115_CR89","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mus.20959","volume":"37","author":"L Mhandi El","year":"2008","unstructured":"El Mhandi L, Millet GY, Calmels P, Richard A, Oullion R, Gautheron V, et al. Benefits of interval\u2009\u2212\u2009training on fatigue and functional capacities in Charcot\u2009\u2212\u2009Marie\u2009\u2212\u2009Tooth disease. Muscle Nerve. 2008;37(5):601\u201310.","journal-title":"Muscle Nerve"},{"issue":"8","key":"115_CR90","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.apmr.2003.12.025","volume":"85","author":"RD Chetlin","year":"2004","unstructured":"Chetlin RD, Gutmann L, Tarnopolsky M, Ullrich IH, Yeater RA. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil. 2004;85(8):1217\u201323.","journal-title":"Arch Phys Med Rehabil"},{"key":"115_CR91","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0003-9993(02)04949-3","volume":"6","author":"P Vinci","year":"2003","unstructured":"Vinci P, Esposito C, Perelli SL, Antenor JA, Thomas FP. Overwork weakness in Charcot Marie Tooth. Arch Phys Med Rehabil. 2003;6:825\u20137.","journal-title":"Arch Phys Med Rehabil"},{"key":"115_CR92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2340\/16501977-0274","volume":"41","author":"M Pomeren van","year":"2009","unstructured":"van Pomeren M, Selles RW, Berbke TJ, et al. The hypothesis of overwork weakness in Charcot-Marie-Tooth: a critical evaluation. J Rehabil Med. 2009;41:32\u20134.","journal-title":"J Rehabil Med"},{"key":"115_CR93","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2340\/16501977-0552","volume":"42","author":"A Videler","year":"2010","unstructured":"Videler A, Beelen A, Nollet F. Verifying the hypotesis of overwork weakness in Charcot-Marie-Tooth. J Rehabil Med. 2010;42:380\u20131.","journal-title":"J Rehabil Med"},{"issue":"2","key":"115_CR94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1836-9553(10)70041-2","volume":"56","author":"KJ Rose","year":"2010","unstructured":"Rose KJ, Raymond J, Refshauge K, North KN, Burns J. Serial night casting increases ankle dorsiflexion range in children and young adults with Charcot-Marie-Tooth disease: a randomised trial. J Physiother. 2010;56(2):113\u201319.","journal-title":"J Physiother"},{"key":"115_CR95","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0004-9514(06)70028-9","volume":"52","author":"KM Refshauge","year":"2006","unstructured":"Refshauge KM, Raymond J, Nicholson G, van den Dolder PA. Night splinting does not increase ankle range of motion in people with Charcot-Marie-Tooth disease: a randomised, cross-over trial. Aust J Physiother. 2006;52:193\u20139.","journal-title":"Aust J Physiother"},{"issue":"3","key":"115_CR96","first-page":"219","volume":"42","author":"P Vinci","year":"2006","unstructured":"Vinci P. Persistence of range of motion in dorsiflexion, when the triceps surae muscles weaken, worsens stance and gait in Charcot-Marie-Tooth disease. A case report. Eura Medicophys. 2006;42(3):219\u201322.","journal-title":"Eura Medicophys"},{"key":"115_CR97","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/00002060-200211001-00015","volume":"81","author":"DD Kilmer","year":"2002","unstructured":"Kilmer DD. Response to aerobic exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil. 2002;81:S148\u201350.","journal-title":"Am J Phys Med Rehabil"},{"issue":"8","key":"115_CR98","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00002060-200108000-00006","volume":"80","author":"J Bean","year":"2001","unstructured":"Bean J, Walsh A, Frontera W. Brace modification improves aerobic performance in Charcot-Marie-Tooth disease: a single subject design. Am J Phys Med Rehabil. 2001;80(8):578\u201382.","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"115_CR99","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1529-8027.2001.01007-51.x","volume":"6","author":"P Vinci","year":"2001","unstructured":"Vinci P, Perelli SL, Esposito C. Charcot-Marie-Tooth disease: poor balance and rehabilitation [abstract]. J Peripher Nerv Syst. 2001;6(1):58.","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"115_CR100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mus.21685","volume":"42","author":"J Burns","year":"2010","unstructured":"Burns J, Scheinberg A, Ryan M, Rose K, Ouvrier R. Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric Charcot-Marie-Tooth disease type 1A. Muscle Nerve. 2010;42(2):262\u20137.","journal-title":"Muscle Nerve"},{"issue":"8","key":"115_CR101","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jnnp.2009.187302","volume":"81","author":"AJ Videler","year":"2010","unstructured":"Videler AJ, Beelen A, Van Schaik IN, Verhamme C, Van Den Berg LH, De Visser M. Nollet F Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A. J Neurol Neurosurg Psychiatry. 2010;81(8):828\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"115_CR102","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2106\/00004623-195739050-00007","volume":"39","author":"EA Zancolli","year":"1957","unstructured":"Zancolli EA. Claw-hand caused by paralysis of the intrinsic muscles: a simple surgical procedure for its correction. J Bone Joint Surg Am. 1957;39(5):1076\u201380.","journal-title":"J Bone Joint Surg Am"},{"key":"115_CR103","first-page":"1077","volume":"118","author":"IK Mikhail","year":"1964","unstructured":"Mikhail IK. Bone block operation for clawhand. Surg Gynecol Obstet. 1964;118:1077\u20139.","journal-title":"Surg Gynecol Obstet"},{"issue":"3","key":"115_CR104","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0072-968X(73)90028-4","volume":"5","author":"A Parkes","year":"1973","unstructured":"Parkes A. Paralytic claw fingers--a graft tenodesis operation. Hand. 1973;5(3):192\u20139.","journal-title":"Hand"},{"issue":"11","key":"115_CR105","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1212\/WNL.38.11.1731","volume":"38","author":"WG Bradley","year":"1988","unstructured":"Bradley WG, Badger GJ, Tandan R, Fillyaw MJ, Young J, Fries TJ, et al. Double-blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia. Neurology. 1988;38(11):1731\u20139.","journal-title":"Neurology"},{"issue":"9","key":"115_CR106","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.36.9.1200","volume":"36","author":"LL Williams","year":"1986","unstructured":"Williams LL, O\u2019Dougherty MM, Wright FS, Bobulski RJ, Horrocks LA. Dietary essential fatty acids, vitamin E, and Charcot-Marie-Tooth disease. Neurology. 1986;36(9):1200\u20135.","journal-title":"Neurology"},{"issue":"1","key":"115_CR107","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0925-4439(95)00040-B","volume":"1271","author":"K Folkers","year":"1995","unstructured":"Folkers K, Simonsen R. Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochim Biophys Acta. 1995;1271(1):281\u20136.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"115_CR108","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMra0907180","volume":"363","author":"HC Dietz","year":"2010","unstructured":"Dietz HC. New therapeutic approaches to mendelian disorders. N Engl J Med. 2010;363(9):852\u201363.","journal-title":"N Engl J Med"},{"issue":"3","key":"115_CR109","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/mt.2009.306","volume":"18","author":"CR Sibley","year":"2010","unstructured":"Sibley CR, Seow Y, Wood MJ. Novel RNA-based strategies for therapeutic gene silencing. Mol Ther. 2010;18(3):466\u201376.","journal-title":"Mol Ther"},{"issue":"6","key":"115_CR110","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1371\/journal.pgen.0030109","volume":"3","author":"M Wood","year":"2007","unstructured":"Wood M, Yin H, McClorey G. Modulating the expression of disease genes with RNA-based therapy. PLoS Genet. 2007;3(6):e109.","journal-title":"PLoS Genet"},{"issue":"1","key":"115_CR111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2085","volume":"8","author":"TM Rana","year":"2007","unstructured":"Rana TM. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol. 2007;8(1):23\u201336.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"115_CR112","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cub.2006.04.005","volume":"16","author":"T Andl","year":"2006","unstructured":"Andl T, Murchison EP, Liu F, Zhang Y, Yunta-Gonzalez M, Tobias JW, et al. The miRNA-processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles. Curr Biol. 2006;16(10):1041\u20139.","journal-title":"Curr Biol"},{"issue":"22","key":"115_CR113","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.1523\/JNEUROSCI.0876-10.2010","volume":"30","author":"B Yun","year":"2010","unstructured":"Yun B, Anderegg A, Menichella D, Wrabetz L, Feltri ML. Awatramani R. MicroRNA-deficient Schwann cells display congenital hypomyelination. J Neurosci. 2010;30(22):7722\u20138. This paper, along with references [114] and [115], demonstrates for the first time that microRNAs regulate Schwann cells gene expression and are required for myelination of peripheral nerves.","journal-title":"J Neurosci"},{"issue":"12","key":"115_CR114","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/jnr.22418","volume":"88","author":"JD Verrier","year":"2010","unstructured":"Verrier JD, Semple-Rowland S, Madorsky I, Papin JE, Notterpek L. Reduction of Dicer impairs Schwann cell differentiation and myelination. J Neurosci Res. 2010;88(12):2558\u201368. This paper, along with references [113] and [115], demonstrates for the first time that microRNAs regulate Schwann cells gene expression and are required for myelination of peripheral nerves.","journal-title":"J Neurosci Res"},{"issue":"19","key":"115_CR115","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1523\/JNEUROSCI.0801-10.2010","volume":"30","author":"JA Pereira","year":"2010","unstructured":"Pereira JA, Baumann R, Norrm\u00e9n C, Somandin C, Miehe M, Jacob C, et al. Dicer in Schwann cells is required for myelination and axonal integrity. J Neurosci. 2010;30(19):6763\u201375. This paper, along with references [113] and [114], demonstrates for the first time that microRNAs regulate Schwann cells gene expression and are required for myelination of peripheral nerves.","journal-title":"J Neurosci"},{"key":"115_CR116","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/NMM:8:1:255","volume":"8","author":"ME Shy","year":"2006","unstructured":"Shy ME. Therapeutic strategies for the inherited neuropathies. Neuromolecular Med. 2006;8:255\u201378.","journal-title":"Neuromolecular Med"},{"issue":"3","key":"115_CR117","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10072-008-0935-0","volume":"29","author":"L Padua","year":"2008","unstructured":"Padua L, Cavallaro T, Pareyson D, Quattrone A, Vita G. QoL Study Group. Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. Neurol Sci. 2008;29(3):193\u20134.","journal-title":"Neurol Sci"},{"issue":"9","key":"115_CR118","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R, Haanp\u00e4\u00e4 M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113\u2013e88.","journal-title":"Eur J Neurol"},{"key":"115_CR119","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1049909106292169","volume":"23","author":"GT Carter","year":"2006","unstructured":"Carter GT, Han JJ, Mayadev A, Weiss MD. Modafinil Reduces Fatigue in Charcot-Marie-Tooth Disease Type 1A: A Case Series. Am J Hosp Palliat Care. 2006;23:412.","journal-title":"Am J Hosp Palliat Care"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-011-0115-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0115-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T16:19:23Z","timestamp":1712161163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-011-0115-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,1]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["115"],"URL":"https:\/\/doi.org\/10.1007\/s11940-011-0115-z","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,1]]}}}